a purity of about 96%) or by
Heat Treatment.12
C. FURTHER PURIFICATION: Additional removal of impurities can be accomplished by crystallization1,4
(a procedure which yields $99% pure albumin), preparative
Powder
≥96% by agarose gel
Essentially fatty acid free (∼0.005%)
A 9511
1× crystallized and lyophilized.
Prepared from A 1653 using method IV of
Cohn, et al.3
Powder
97-99% by agarose
Powder
≥96% by agarose gel
Essentially fatty acid free (∼0.005%)
A 9511
1× crystallized and lyophilized.
Prepared from A 1653 using method IV of
Cohn, et al.3
Powder
97-99% by agarose
Powder
≥96% by agarose gel
Essentially fatty acid free (∼0.005%)
A 9511
1× crystallized and lyophilized.
Prepared from A 1653 using method IV of
Cohn, et al.3
Powder
97-99% by agarose
Powder
≥96% by agarose gel
Essentially fatty acid free (∼0.005%)
A 9511
1× crystallized and lyophilized.
Prepared from A 1653 using method IV of
Cohn, et al.3
Powder
97-99% by agarose
Powder
≥96% by agarose gel
Essentially fatty acid free (∼0.005%)
A 9511
1× crystallized and lyophilized.
Prepared from A 1653 using method IV of
Cohn, et al.3
Powder
97-99% by agarose
Powder
≥96% by agarose gel
Essentially fatty acid free (∼0.005%)
A 9511
1× crystallized and lyophilized.
Prepared from A 1653 using method IV of
Cohn, et al.3
Powder
97-99% by agarose
Powder
≥96% by agarose gel
Essentially fatty acid free (∼0.005%)
A 9511
1× crystallized and lyophilized.
Prepared from A 1653 using method IV of
Cohn, et al.3
Powder
97-99% by agarose
Powder
≥96% by agarose gel
Essentially fatty acid free (∼0.005%)
A 9511
1× crystallized and lyophilized.
Prepared from A 1653 using method IV of
Cohn, et al.3
Powder
97-99% by agarose
Powder
≥96% by agarose gel
Essentially fatty acid free (∼0.005%)
A 9511
1× crystallized and lyophilized.
Prepared from A 1653 using method IV of
Cohn, et al.3
Powder
97-99% by agarose
Powder
≥96% by agarose gel
Essentially fatty acid free (∼0.005%)
A 9511
1× crystallized and lyophilized.
Prepared from A 1653 using method IV of
Cohn, et al.3
Powder
97-99% by agarose
Bead-Beating Master Mix per well of Tube Strips.
Number of samples 1 96 (+20%)
Bead-Beating Buffer 99 µL 11,404.8 µL
RNase A Plant 1 µL 115.2 µL
Final Volume 100 µL 11,520 µL
•
Bead-Beating Master Mix per well of Tube Strips.
Number of samples 1 96 (+20%)
Bead-Beating Buffer 99 µL 11,404.8 µL
RNase A Plant 1 µL 115.2 µL
Final Volume 100 µL 11,520 µL
•
Powder
96% by agarose gel
Essentially fatty acid free (0.005%)
A 9511 1crystallized and lyophilized.
Prepared from A 1653 using method IV of
Cohn, et al.3
Powder
97-99% by agarose gel
Bead-Beating
Master Mix per well of Tube Strips.
Number of samples 1 96 (+20%)
Bead-Beating Buffer 99 µL 11,404.8 µL
RNase A Plant 1 µL 115.2 µL
Final Volume 100 µL 11,520 µL
61-2
PRODUCT DESCRIPTION:
Equine muscle source, high purity (not less than 99%), low vanadium content (less than 1 ppm),
recommended for general enzyme applications and bioluminescent experiments